Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2/3, Open Label, Randomised Study of the Safety, Reactogenicity and Immunogenicity of a Single Dose of Novartis Meningococcal ACWY (Menveo) or GSK Meningococcal ACWY Conjugate Vaccine in Adolescents Primed With Meningitec, Menjugate or Neisvac-C in Preschool Vaccination

NCT01192997 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.

NCT NCT01192997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01192997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2/3, Open Label, Randomised Study of the Safety, Reactogenicity and Immunogenicity of a Single Dose of Novartis Meningococcal ACWY (Menveo) or GSK Meningococcal ACWY Conjugate Vaccine in Adolescents Primed With Meningitec, Menjugate or Neisvac-C in Preschool Vaccination
Lead sponsor
Public Health England
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2012
Completion date
March 31, 2014
Enrollment
91 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal meningitis